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letter to editorDengue fever as a cause of
febrile neutropenia in adult
acute lymphoblastic
leukemia: A single center
experienceDengue fever is an arboviraldisease with a wide spec-trum of manifestations,
ranging from a benign self-limited
course to severe life-threatening
illness in the form of dengue
hemorrhagic fever / dengue shock
syndrome (DHF/DSS). It is a
signiﬁcant public health issue in
countries like India.1 There are
few reports on dengue as a cause
of febrile neutropenia (FN). Its
diagnosis requires a high index of
suspicion, and it has important
therapeutic implications. We ret-
rospectively evaluated the proﬁle
and outcomes of dengue in adult
acute lymphoblastic leukemia
(ALL) being treated at our center.
The medical records of all cases
of febrile neutropenia in patients
of acute lymphoblastic leukemia,
aged 15 years, treated at Tata
Memorial Hospital from January
2013 to October 2013 were retro-
spectively analyzed.
A total of eight acute lympho-
blastic leukemia patients developed
dengue fever and their data wereTable 1. Clinicopathological profile of ALL patien
No. Phase of protocol Diagnosis Sym
1 Delayed Reintensification DHF Fever,
2 Reinduction DF
3 Reinduction DF
4 Reinduction DF
5 Reinduction DF
6 Reinduction DF
7 Maintenance DF
8 Maintenance DF Feve
Hematol Oncol Stem Cell Ther 7(3) Third Quanalyzed. Diagnosis of dengue
infection was made through
screening with a Dengue NS1
antigen, and conﬁrmed with an
IgM and IgG capture enzyme-
linked immunosorbent assay. We
analyzed patient case records for
symptomatology, clinical course,
laboratory values, transfusion
requirements, dose intensity of
chemotherapy, and outcomes.
Eight out of 126 ALL patients
had dengue infection. Their clini-
cal proﬁles are described in
Table 1. Dengue NS1 antigen
was positive in all eight cases. All
eight patients had classical dengue
fever. Fever, myalgia and body ache
were the most common symptoms.
The median platelet count at pre-
sentation was 219,500/mm3
(range: 119,000–294,000/mm3).
The patients had a median nadir
platelet count of 42,500/mm3
(range: 8000–74,000/mm3). Med-
ian time to recovery of platelet was
9.5 days (0–18 days). Four
patients required platelet transfu-
sion. The highest hemoglobin level
(median value) was 12 g/dL. The
median hematocrit at diagnosis
was 29.8% (range: 23.6–39.4%).
All patients had deranged liver
function in the form of transamini-
tis. The median delay in thets with dengue fever.
ptoms on admission Hb g/dl (Max) Lowest pla
myalgia, abdominal pain 10.1 80
Fever, myalgia 11.6 30,
Fever, myalgia 12.8 17,
Fever, myalgia 10.5 55,
Fever, myalgia 13.5 60,
Fever 9.1 62,
Fever, myalgia 12.5 21,
r, headache, myalgia 12.5 74,
arter 2014 hemoncstem.edmgr.comadministration of chemotherapy
was ten days (0–18 days), though
the subsequent chemotherapy was
well tolerated. All patients recov-
ered with supportive measures.
Febrile neutropenia (FN) due
to dengue has signiﬁcant differ-
ences in clinical features to FN
due to causes other than dengue.
These include disproportionate
myalgias, headache and retro-
orbital pain. FN is a common
complication in the management
of adult ALL. Viral and parasitic
infections are less frequently reported
as the cause of FN, but they remain
a potential concern especially in
developing countries. Identiﬁca-
tion of dengue as a potential cause
for fever in acute leukemia patients
is important as the management of
dengue fever focuses mainly on
supportive measures like ﬂuid
therapy. Dengue infection can lead
to cytopenias, and contributes to
the myelosuppression of chemo-
therapy, which can affect the
intensity of chemotherapy with
adverse effects on the outcomes
of ALL. Cytopenias could also
increase the risk of a secondary
bacterial infection. In addition, it
increases the need for supportive
care in the form of growth factors
and transfusion of blood and bloodtelet/mm3 Platelet support Complications SGOT/SGPT Outcome
00 Yes No 84/60 Recovered
000 Yes Ischemic retinopathy 319/245 Recovered
000 Yes No 67/85 Recovered
000 No No 178/41 Recovered
000 No No 444/775 Recovered
000 No No 238/52 Recovered
000 Yes No 150/119 Recovered
000 Yes No 156/130 Recovered
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products. The clinical proﬁle of
dengue in ALL is insufﬁciently
studied. In our patients, fever
and myalgia were the most
common presenting symptoms.
The median nadir platelet counts
were 42,000/mm3.
In an interesting observation,
one of our patients (patient No.
7) had presented at the end of
his maintenance chemotherapy
with fever, pancytopenia and atyp-
ical lymphocytes, raising the con-
cern of disease relapse. However,
he had complete resolution of
cytopenias and is now on follow
up.
A recent case series of dengue
in pediatric ALL patients high-
lights the importance of maintain-
ing a high index of suspicion for
dengue in cases of febrile neutro-penia, and reports a delay in plate-
let recovery in ALL patients with
dengue as compared to cases of
dengue without ALL.2
Our study highlights the
importance of relevant history-
taking to make appropriate and
early diagnosis. In addition, close
monitoring and early ﬂuid therapy
is relevant to avert complications.CONFLICT OF INTEREST
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